Adial Pharmaceuticals Inc — Cash Flow (NASDAQ:ADIL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 7.63 M-11.95 M-11.19 M-6.81 M-6.92 M -6.62 M Cash from investing activities 350 K-34.02 K01.5 M0 150 K Cash from financing activities 5.61 M13.64 M9.13 M4.13 M7.85 M 5.87 M Free cash flow 7.63 M-12.01 M-11.19 M-6.81 M-6.92 M -6.62 M

News

Adial Pharmaceuticals stock rises on FDA policy shift

Adial Pharmaceuticals eyes single pivotal trial path for AD04

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com

Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split

Adial Pharmaceuticals announces 1-for-25 reverse stock split

Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr.

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Adial Pharmaceuticals raises $2.86 million through warrant exercise

Adial completes key validation for alcohol disorder treatment test

This Semtech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Celsius Holdings (NASDAQ:CELH), Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals receives 180-day Nasdaq extension to meet $1 bid price

All You Need to Know About Adial Pharmaceuticals (ADIL) Rating Upgrade to Buy